Literature DB >> 19631880

Percutaneous radiofrequency ablation: a novel treatment of facial venous malformation.

Ah Hyun Kim1, Heung Kyu Ko, Jong Yun Won, Do Yun Lee.   

Abstract

We performed radiofrequency ablation to treat a symptomatic facial venous malformation of a 24-year-old woman under ultrasound scan-guidance. The 20.25-cm sized original facial venous malformation in her right cheek markedly reduced without any scar formation and was grossly not visible after 1 month of the procedure. In the 3-month follow-up magnetic resonance imaging, original venous malformation reduced in volume to 5.40 cm. Radiofrequency ablation may provide an alternative treatment for facial venous malformations.

Entities:  

Mesh:

Year:  2009        PMID: 19631880     DOI: 10.1016/j.jvs.2009.03.047

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  6 in total

Review 1.  Percutaneous Image-Guided Cryoablation in Vascular Anomalies.

Authors:  Raja Shaikh
Journal:  Semin Intervent Radiol       Date:  2017-09-11       Impact factor: 1.513

2.  Initial Results of Image-Guided Percutaneous Ablation as Second-Line Treatment for Symptomatic Vascular Anomalies.

Authors:  Scott M Thompson; Matthew R Callstrom; Michael A McKusick; David A Woodrum
Journal:  Cardiovasc Intervent Radiol       Date:  2015-04-01       Impact factor: 2.740

Review 3.  Update on pediatric extracranial vascular anomalies of the head and neck.

Authors:  Katherine B Puttgen; Monica Pearl; Aylin Tekes; Sally E Mitchell
Journal:  Childs Nerv Syst       Date:  2010-08-10       Impact factor: 1.475

4.  Long-Term Outcome of Single-Session, Ultrasound-Guided, Radiofrequency Ablation for Symptomatic Small, Lower Limb, Venous Malformations.

Authors:  Laurence Verhaeghe; Veerle Labarque; Jan Vranckx; Inge Fourneau; Steven Pans; Geert Maleux
Journal:  J Belg Soc Radiol       Date:  2022-07-13       Impact factor: 1.912

5.  Curative effects of RF combined with DSA-guided ethanol sclerotherapy in venous malformations.

Authors:  Xing Wang; Jian Meng; Jie Zhang; Ruihan Wu; Jianmin Gu; Cuiling Shao; Kun Han
Journal:  Exp Ther Med       Date:  2016-10-13       Impact factor: 2.447

Review 6.  Management of aggressive fibromatosis.

Authors:  Zhijun Zhang; Jian Shi; Tao Yang; Tongjun Liu; Kai Zhang
Journal:  Oncol Lett       Date:  2020-11-17       Impact factor: 2.967

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.